Avian influenza (bird flu) is an infection caused by influenza viruses
that chiefly infect birds and poultry. The H5N1 strain (named for the characteristics
of
the
viral
surface
proteins
hemagglutinin
and
neuraminidase) is of particular concern. It has caused a number of
outbreaks in poultry since 2003, and the problem is ongoing; flocks of migratory birds have rapidly disseminated the virus throughout much of the world. Although many avian influenza viruses are natural and nonpathogenic in birds, H5N1 is unusual because of its high mortality rate in birds and because it has shown a limited ability to be transmitted from a bird source to mammals, including humans. The human mortality rate from H5N1 avian influenza has been more than 60% (WHO, 2008a). The majority of human cases of H5N1 are attributed to direct contact with poultry, but there are rare instances that suggest occasional humanto-human transmission. Scientists are especially concerned that avian influenza H5N1 may change, either through mutation or reassortment, to become easily transmitted from human to human. If H5N1 were easily transmissible to humans, it would be likely to cause a severe pandemic because the human population has no immunity to the virus and because development of an appropriate vaccine would take too long to effectively stop the pandemic (U.S. Department of Health and Human Services [USDHHS], 2008). Nursing Care Plan 1. ASSESSMENT
The symptoms associated with H5N1 avian influenza in humans
have ranged from the symptoms typically seen with seasonal influenza (cough, fever, and muscle aches) to severe pneumonia and multiorgan failure. Symptoms of flu include abrupt onset of fever, chills, myalgia, sore throat, cough, general malaise, and headache. It can last for 2 to 5 days, with malaise lasting up to several weeks. 2. NURSING DIAGNOSIS, OUTCOME AND INTERVENTION
a. Diagnosis : Risk for Deficient Fluid Volume, risk factor :
Inadequate intake of fluids
Expected Outcome : Fluid Balance, adequate intake of fluids Intervention : b. Impaired Gas Exchange c. Deficient knowledge
SEVERE ACUTE RESPIRATORY SYNDROME
Severe acute respiratory syndrome (SARS) is a viral respiratory illness caused by a coronavirus, called SARS-associated coronavirus. It was first reported in Asia in 2003 and quickly spread to countries in North America, South America, Europe, and Asia. The World Health Organization (WHO) reported that 8422 people worldwide became sick with SARS during the 2003 outbreak, and 916 died (Hirsch, 2007). SARS develops in people who either have close contact with a person who has been diagnosed with the disease or a history of travel or residence in an area with known cases. The SARS-associated coronavirus is transmitted via respiratory droplets when an infected person coughs or sneezes; the droplets may be deposited on the mucous membranes (mouth, nose, eyes) of a nearby person. The virus may also be spread when a person touches a surface or object contaminated by the droplets and then touches his or her mucous membranes. The virus may be transmitted in other ways, including sewage and water, but these methods of transmission are unclear at this time (Hirsch, 2007). Nursing Care Plan 1. ASSESSMENT
Characteristic symptoms of SARS are a fever (greater than
38.0_C [100.4_F]), coughing, and difficulty breathing. The incubation period is usually 2 to 7 days; however, longer periods have been reported. About 95% of patients develop symptoms within 10 days (Hirsch, 2007). 2. NURSING DIAGNOSIS, OUTCOME AND INTERVENTION a. Impaired Gas Exchange